News

Ophthalmology Times6h
NEW DAY trial of ILUVIEN for DME does not meet primary endpoint, post-hoc analysis suggests potential benefits
Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...
Ophthalmology Times19h
Q&A: Natalie Afshari, MD, FACS, championing on-label pediatric IOLs: turning advocacy into access
Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance clinical and patient care.